Invivyd IVVD
NASDAQ IVVD
$0.83 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Invivyd (IVVD) Accounts Payables (2020 - 2026)

Invivyd's (IVVD) quarterly Accounts Payables came in at $9.5 million in Q2 2026, down 47.45% on a YoY basis from $18.1 million in Q2 2025, and down 30.98% quarter-over-quarter from $13.7 million in Q4 2025.

Analysis

Invivyd (IVVD) Accounts Payables (2020 - 2026) Analysis & Trends

Invivyd (IVVD) has reported Accounts Payables for 7 consecutive years, with $9.5 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Accounts Payables fell 47.45% year-over-year to $9.5 million; the trailing twelve-month figure through Jun 2026 stood at $9.5 million (down 47.45% YoY), and the FY2025 full-year result was $13.7 million, up 31.55% from the prior year.
  • Accounts Payables declined to $9.5 million in Q2 2026 per IVVD's latest filing, from $13.7 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $18.7 million in Q1 2022 and bottomed at $1.2 million in Q1 2024.
  • Historically, Accounts Payables has averaged $10.8 million across 5 years, with a median of $9.5 million in 2026.
  • The sharpest annual moves came in 2024 and 2025: Accounts Payables sank 80.25% in 2024, then surged 648.2% in 2025.
  • Over 5 years, Accounts Payables stood at $1.5 million in 2022, then surged by 424.26% to $8.0 million in 2023, then soared by 31.37% to $10.4 million in 2024, then surged by 31.55% to $13.7 million in 2025, then tumbled by 30.98% to $9.5 million in 2026.
  • According to Business Quant data, Accounts Payables over the past three periods registered $9.5 million, $13.7 million, and $18.1 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 2.87 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 674.00 Mn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 429.50 Mn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 1.16 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 1.52 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 167.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 108.02 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 403.90 Mn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 428.93 Mn
10 Invivyd 244.65 Mn 84.57 Mn 13.01 Mn 9.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.49 Mn
Dec 31, 2025 13.74 Mn
Sep 30, 2025 18.10 Mn
Jun 30, 2025 18.05 Mn
Mar 31, 2025 8.74 Mn
Dec 31, 2024 10.45 Mn
Sep 30, 2024 17.71 Mn
Jun 30, 2024 7.50 Mn
Mar 31, 2024 1.17 Mn
Dec 31, 2023 7.95 Mn
Sep 30, 2023 9.17 Mn
Jun 30, 2023 4.11 Mn
Mar 31, 2023 5.91 Mn
Dec 31, 2022 1.52 Mn
Sep 30, 2022 16.77 Mn
Jun 30, 2022 14.23 Mn
Mar 31, 2022 18.68 Mn
Dec 31, 2021 5.78 Mn
Sep 30, 2021 17.56 Mn
Jun 30, 2021 10.72 Mn